These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
394 related items for PubMed ID: 15850403
41. Importance of the amino terminus in secretin family G protein-coupled receptors. Intrinsic photoaffinity labeling establishes initial docking constraints for the calcitonin receptor. Dong M, Pinon DI, Cox RF, Miller LJ. J Biol Chem; 2004 Jan 09; 279(2):1167-75. PubMed ID: 14583624 [Abstract] [Full Text] [Related]
42. Stereospecific synthesis of a carbene-generating angiotensin II analogue for comparative photoaffinity labeling: improved incorporation and absence of methionine selectivity. Fillion D, Deraët M, Holleran BJ, Escher E. J Med Chem; 2006 Apr 06; 49(7):2200-9. PubMed ID: 16570916 [Abstract] [Full Text] [Related]
43. CCK1 and 2 receptors are expressed in immortalized rat brain neuroblasts: intracellular signals after cholecystokinin stimulation. Langmesser S, Cerezo-Guisado MI, Lorenzo MJ, Garcia-Marin LJ, Bragado MJ. J Cell Biochem; 2007 Mar 01; 100(4):851-64. PubMed ID: 17226751 [Abstract] [Full Text] [Related]
44. Fluorescence characteristics of hydrophobic partial agonist probes of the cholecystokinin receptor. Harikumar KG, Pinon DI, Miller LJ. Biosci Rep; 2006 Apr 01; 26(2):89-100. PubMed ID: 16779661 [Abstract] [Full Text] [Related]
45. Conformationally constrained CCK8 analogues obtained from a rationally designed peptide library as ligands for cholecystokinin type B receptor. De Luca S, Saviano M, Della Moglie R, Digilio G, Bracco C, Aloj L, Tarallo L, Pedone C, Morelli G. ChemMedChem; 2006 Sep 01; 1(9):997-1006. PubMed ID: 16915602 [Abstract] [Full Text] [Related]
46. Conformational and molecular modeling studies of beta-cyclodextrin-heptagastrin and the third extracellular loop of the cholecystokinin 2 receptor. Giragossian C, Schaschke N, Moroder L, Mierke DF. Biochemistry; 2004 Mar 16; 43(10):2724-31. PubMed ID: 15005607 [Abstract] [Full Text] [Related]
47. Elucidation of the molecular basis of cholecystokinin Peptide docking to its receptor using site-specific intrinsic photoaffinity labeling and molecular modeling. Dong M, Lam PC, Pinon DI, Abagyan R, Miller LJ. Biochemistry; 2009 Jun 16; 48(23):5303-12. PubMed ID: 19441839 [Abstract] [Full Text] [Related]
50. Structurally related peptide agonist, partial agonist, and antagonist occupy a similar binding pocket within the cholecystokinin receptor. Rapid analysis using fluorescent photoaffinity labeling probes and capillary electrophoresis. Dong M, Ding XQ, Pinon DI, Hadac EM, Oda RP, Landers JP, Miller LJ. J Biol Chem; 1999 Feb 19; 274(8):4778-85. PubMed ID: 9988716 [Abstract] [Full Text] [Related]
51. Identification of peptide ligand-binding domains within the human motilin receptor using photoaffinity labeling. Coulie B, Matsuura B, Dong M, Hadac EM, Pinon DI, Feighner SD, Howard AD, Miller LJ. J Biol Chem; 2001 Sep 21; 276(38):35518-22. PubMed ID: 11461914 [Abstract] [Full Text] [Related]
52. Biochemical characterization of the cholecystokinin receptor on CHP212 human neuroblastoma cells. Klueppelberg UG, Molero X, Barrett RW, Miller LJ. Mol Pharmacol; 1990 Aug 21; 38(2):159-63. PubMed ID: 2200953 [Abstract] [Full Text] [Related]
53. Further evidence for a C-terminal structural motif in CCK2 receptor active peptide hormones. Stone SR, Giragossian C, Mierke DF, Jackson GE. Peptides; 2007 Nov 21; 28(11):2211-22. PubMed ID: 17950490 [Abstract] [Full Text] [Related]
54. Transmembrane domain V of the endothelin-A receptor is a binding domain of ETA-selective TTA-386-derived photoprobes. Tessier S, Boivin S, Aubin J, Lampron P, Detheux M, Fournier A. Biochemistry; 2005 May 31; 44(21):7844-54. PubMed ID: 15909998 [Abstract] [Full Text] [Related]
55. Demonstration of a direct interaction between residue 22 in the carboxyl-terminal half of secretin and the amino-terminal tail of the secretin receptor using photoaffinity labeling. Dong M, Wang Y, Pinon DI, Hadac EM, Miller LJ. J Biol Chem; 1999 Jan 08; 274(2):903-9. PubMed ID: 9873030 [Abstract] [Full Text] [Related]
56. Spatial approximation between the C-terminus of VIP and the N-terminal ectodomain of the VPAC1 receptor. Ceraudo E, Tan YV, Couvineau A, Lacapere JJ, Laburthe M. Ann N Y Acad Sci; 2006 Jul 08; 1070():180-4. PubMed ID: 16888162 [Abstract] [Full Text] [Related]
57. Role of cholecystokinin-A and cholecystokinin-B receptors in anxiety. Hernandez-Gómez AM, Aguilar-Roblero R, Pérez de la Mora M. Amino Acids; 2002 Jul 08; 23(1-3):283-90. PubMed ID: 12373548 [Abstract] [Full Text] [Related]
58. Photolabelling the urotensin II receptor reveals distinct agonist- and partial-agonist-binding sites. Holleran BJ, Beaulieu ME, Proulx CD, Lavigne P, Escher E, Leduc R. Biochem J; 2007 Feb 15; 402(1):51-61. PubMed ID: 17064254 [Abstract] [Full Text] [Related]
59. Insights into the structure and molecular basis of ligand docking to the G protein-coupled secretin receptor using charge-modified amino-terminal agonist probes. Dong M, Pinon DI, Miller LJ. Mol Endocrinol; 2005 Jul 15; 19(7):1821-36. PubMed ID: 15731172 [Abstract] [Full Text] [Related]
60. Receptor fragment approach to the binding between CCK8 peptide and cholecystokinin receptors: a fluorescence study on type B receptor fragment CCK(B)-R (352-379). De Luca S, Sanseverino M, Zocchi I, Pedone C, Morelli G, Ragone R. Biopolymers; 2005 Mar 15; 77(4):205-11. PubMed ID: 15666329 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]